Citadel Advisors - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 206 filers reported holding MYRIAD GENETICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$11,750,005
+705.0%
732,544
+1063.3%
0.00%
Q2 2023$1,459,715
-21.5%
62,973
-21.3%
0.00%
Q1 2023$1,859,445
+24.1%
80,045
-22.5%
0.00%
Q4 2022$1,498,839
+188.8%
103,297
+279.8%
0.00%
Q3 2022$519,000
-56.0%
27,200
-58.1%
0.00%
Q2 2022$1,179,000
-61.7%
64,900
-46.9%
0.00%
Q1 2022$3,077,000
-25.6%
122,122
-18.5%
0.00%
Q4 2021$4,134,000
-37.1%
149,824
-26.4%
0.00%
-100.0%
Q3 2021$6,574,000
+3.5%
203,554
-2.0%
0.00%0.0%
Q2 2021$6,352,000
-17.0%
207,716
-17.4%
0.00%0.0%
Q1 2021$7,656,000
+237.4%
251,474
+119.1%
0.00%
Q4 2020$2,269,000
+84.9%
114,758
+21.9%
0.00%
Q3 2020$1,227,000
-1.8%
94,131
-14.5%
0.00%
Q2 2020$1,249,000
-48.6%
110,090
-35.2%
0.00%
-100.0%
Q1 2020$2,430,000
-10.4%
169,818
+70.5%
0.00%0.0%
Q4 2019$2,712,000
-37.5%
99,600
-34.2%
0.00%0.0%
Q3 2019$4,336,000
-73.4%
151,474
-74.1%
0.00%
-85.7%
Q2 2019$16,276,000
+54.4%
585,891
+84.6%
0.01%
+16.7%
Q1 2019$10,540,000
+5.6%
317,449
-7.6%
0.01%
+20.0%
Q4 2018$9,984,000
-20.4%
343,490
+26.0%
0.01%0.0%
Q3 2018$12,543,000
+124.1%
272,666
+82.1%
0.01%
+150.0%
Q2 2018$5,598,000
+87.2%
149,775
+47.9%
0.00%0.0%
Q1 2018$2,991,000
-37.2%
101,236
-27.0%
0.00%
-33.3%
Q4 2017$4,763,000
+57.1%
138,714
+65.5%
0.00%
+50.0%
Q3 2017$3,032,000
-7.6%
83,812
-34.0%
0.00%0.0%
Q2 2017$3,283,000
-8.2%
127,058
-31.8%
0.00%
-50.0%
Q1 2017$3,575,000
-57.7%
186,222
-63.2%
0.00%
-50.0%
Q4 2016$8,447,000
-71.5%
506,721
-64.8%
0.01%
-72.4%
Q3 2016$29,645,000
+634.2%
1,440,460
+991.6%
0.03%
+480.0%
Q2 2016$4,038,000
-27.6%
131,959
-11.4%
0.01%
-28.6%
Q1 2016$5,576,000
+1497.7%
148,978
+1743.1%
0.01%
Q4 2015$349,000
-12.5%
8,083
-24.1%
0.00%
Q3 2015$399,000
+18.0%
10,656
+7.3%
0.00%
Q2 2015$338,000
+263.4%
9,931
+264.4%
0.00%
Q4 2014$93,000
-9.7%
2,725
+2.1%
0.00%
Q3 2014$103,000
-85.8%
2,668
-85.6%
0.00%
-100.0%
Q2 2014$723,000
-70.2%
18,569
-73.8%
0.00%
-66.7%
Q1 2014$2,428,000
-48.5%
71,003
-68.4%
0.00%
-50.0%
Q4 2013$4,718,000
-42.8%
224,885
-36.0%
0.01%
-53.8%
Q3 2013$8,255,000
+499.9%
351,254
+585.8%
0.01%
+550.0%
Q2 2013$1,376,00051,2150.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders